HomePLRX • NASDAQ
add
Pliant Therapeutics Inc
Previous close
$11.90
Year range
$11.73 - $30.35
Market cap
716.85M USD
Avg Volume
331.78K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
(USD) | Dec 2023info | Y/Y change |
---|---|---|
Revenue | 0.00 | -100.00% |
Operating expense | 47.04M | 19.49% |
Net income | -41.11M | -17.25% |
Net profit margin | — | — |
Earnings per share | -0.69 | 4.17% |
EBITDA | -46.57M | -26.06% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
(USD) | Dec 2023info | Y/Y change |
---|---|---|
Cash and short-term investments | 494.24M | 49.23% |
Total assets | 512.15M | 46.07% |
Total liabilities | 38.58M | 3.51% |
Total equity | 473.58M | — |
Shares outstanding | 60.24M | — |
Price to book | 1.51 | — |
Return on assets | -22.34% | — |
Return on capital | -23.52% | — |
Cash Flow
Net change in cash
(USD) | Dec 2023info | Y/Y change |
---|---|---|
Net income | -41.11M | -17.25% |
Cash from operations | -25.10M | 19.65% |
Cash from investing | 31.92M | 59.43% |
Cash from financing | 219.00K | -22.89% |
Net change in cash | 7.04M | 164.37% |
Free cash flow | -18.71M | -4.59% |
About
Founded
2015
Headquarters
Website
Employees
158